
Reset all filters
01 3Vosevi
Sofosbuvir, Velpatasvir, Voxilaprevir
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2017 Revenue in Millions : 293
2016 Revenue in Millions : New Launch
Growth (%) : New Launch
Sofosbuvir, Velpatasvir, Voxilaprevir
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2018 Revenue in Millions : 396
2017 Revenue in Millions : 293
Growth (%) : 35%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 257
2018 Revenue in Millions : 396
Growth (%) : -35